Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity

Acta Diabetologica

Volumn 49, Issue 6, 2012, Pages 465-472

  Ying, Xin ^a   Qian, Yafang ^a   Jiang, Yan ^a   Jiang, Zhenyan ^a   Song, Zhenya ^a   Zhao, Changjun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Abdominal obesity; Apolipoprotein; Cholesterol; Insulin resistance; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD SAMPLING; CHINESE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEALTH SERVICE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84875213017     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-012-0419-9     Document Type: Article

References (37)

1. Hu G, Qiao Q, Tuomilehto J et al (2004) Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 47:1245-1256
2. Choi K, Kim YB (2010) Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med 25:119-129
3. Balkau B, Charles MA, Drivsholm T et al (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364-376
4. Alberti KG, Zimmet P, Shaw J et al (2005) The metabolic syndrome: a new world wide definition. Lancet 366:1059-1062
5. Howard BV, Robbins DC, Sievers ML et al (2000) LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the strong heart study. Arterioscler Thromb Vasc Biol 20:830-835
6. Wallenfeldt K, Bokemark L, Wikstrand J et al (2004) Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35:2248-2252
7. Dahlén EM, Länne T, Engvall J et al (2009) Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle- aged patients with Type 2 diabetes. Diabet Med 26:384-390
8. Sierra-Johnson J, Romero-Corral A, Somers VK et al (2007) ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J 28:2637-2643
9. Onat A, Hergenc G, Sari I et al (2007) Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men: relative roles of insulin resistance and central obesity. Circ J 71:1463-1467
10. Walldius G, Jungner I (2006) The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipidlowering therapy-a review of the evidence. J Intern Med 259:493-519
11. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome: a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469-480
12. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI et al (2004) Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109:551-556
13. Jung CH, Hwang JY, Yu JH et al. (2012) The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population. Clin Endocrinol (Oxf) [Epub ahead of print]
14. Koskinen J, Magnussen CG, Würtz P et al. (2011) Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the cardiovascular risk in young finns study. Eur J Cardiovasc Prev Rehabil [Epub ahead of print]
15. Eglit T, Rajasalu T, Lember M (2012) Metabolic syndrome in estonia: prevalence and associations with insulin resistance. Int J Endocrinol. Art ID: 951672 [Epub ahead of print]
16. Mehta NN, Krishnamoorthy P, Martin SS et al (2011) Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus. Am J Cardiol 107:406-411
17. http://www.dtu.ox.ac.uk/homa/index (2007)
18. Wittchen HU, Balkau B, Massien C et al (2006) International day for the evaluation of abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries. Eur Heart J 8(Suppl B):B26-B33
19. Li C, Ford ES, McGuire LC et al (2007) Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 15:216-224
20. Canoy D, Boekholdt SM, Wareham N et al (2007) Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in norfolk cohort: a population-based prospective study. Circulation 116:2933-2943
21. Fox KA, Després JP, Richard AJ et al (2009) Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur Heart J 30:3055-3063
22. Lafortuna CL, Agosti F, De Col A et al (2012) Prevalence of the metabolic syndrome and its components among obese men and women in Italy. Obes Facts 5(1):127-137
23. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495
24. Wang JB, Zhang YJ, Zhang Y et al. (2010) Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus. Acta Diabetol [Epub ahead of print]
25. Williams K, Sniderman AD, Sattar N et al (2003) Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the insulin resistance atherosclerosis study (IRAS). Circulation 108:2312-2316
26. Sattar N, Williams K, Sniderman AD et al (2004) Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the insulin resistance atherosclerosis study. Circulation 110:2687-2693
27. Ragogna F, Lattuada G, Ruotolo G et al (2012) Lack of association of apoE e4 allele with insulin resistance. Acta Diabetol 49(1):25-32
28. Walldius G, Jungner I (2005) Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26:210-212
29. Walldius G, Jungner I, Holme I et al (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026-2033
30. Holme I, Aastveit AH, Hammar N et al (2009) Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the apolipoprotein mortality risk study (AMORIS). Eur J Heart Fail 11(11):1036-1042
31. Jeppesen J, Hein HO, Suadicani P et al (1998) Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen male study. Circulation 97:1029-1036
32. Walldius G, Aastveit AH, Jungner I (2006) Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. J Intern Med 259:259-266
33. Schmidt C, Fagerberg B (2008) ApoB/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol. Atherosclerosis 196:817-822
34. Bagry HS, Raghavendran S, Carli F (2008) Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology 108:506-523
35. Sierra-Johnson J, Somers VK, Kuniyoshi FH et al (2006) Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome. Am J Cardiol 98(10):1369-1373
36. Belfki H, Ben Ali S, Bougatef S et al (2011) The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population. Exp Mol Pathol 91(2):622-625
37. Festa A, D'Agostino R, Howard G et al (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102:42-47